Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cell Immunol. 2014 May 21;290(1):80–88. doi: 10.1016/j.cellimm.2014.05.005

Figure 4. ADAM10 deficiency enhances SCF-induced proliferation and survival.

Figure 4

(A) WT and ADAM10 KO BMMC were treated with 1ng/ml IL-3 and varying amounts of SCF as indicated for 4 days. Live cell numbers were measured by cell counting. (B) Survival of WT and ADAM10 KO BMMC was measured using various amounts of SCF as indicated over the course of 3 days. Data shown in A and B means and SEM of 15–18 samples from 2 independent experiments. *p <.05; **p<.01; ***p <.001.